Dignity and early diagnosis lead IADVL Karnataka conference

The 17th Annual Conference of the IADVL Karnataka branch convened at DVH Kalakshetra in Dharwad on Sunday under the auspices of SDM University. The meeting paired a conference program with an exhibition. Its theme was “Skinnovation – Innovations in Dermatology, Evolving Aesthetics and Emerging AI.”

What did the conference prioritize?

At the opening, Dr S Sacchidanand, former vice-chancellor of RGUHS, set a clear standard: “Patients must be treated with dignity and respect.” His point addressed both conduct and clinical purpose. Skin conditions can affect identity and quality of life, so dermatology should address the patient’s experience rather than treating the consultation as a skin-only problem.

Dr Sacchidanand also placed the specialty within a wider clinical responsibility. “Dermatology is an integral part of the overall healthcare system,” he said. The goal for every dermatologist, according to him, should be to improve quality of life and avoid leaving patients isolated by their skin conditions.

That statement assigns dermatology broad responsibility, but the report gives no indication of how that integration is organized across services. It also provides no referral pathway, access measure or clinical standard for testing whether the broader goal improves care. The proposal therefore remains a professional commitment rather than a documented change in outcomes.

Within the conference theme, emerging artificial intelligence (AI) sat alongside innovation in dermatology and evolving aesthetics. Yet the report identifies no particular innovation, study, device, injectable formulation, regulatory decision or AI tool. The title establishes scope, not evidence of efficacy or safety, and it does not explain which clinical questions the three strands share.

Sacchidanand also emphasized what he described as transformative progress in dermatology and the importance of early diagnosis and appropriate treatment for skin disorders. No specific condition, patient cohort, diagnostic threshold or treatment outcome appears in the account. Those omissions prevent evaluation of whether “early” means a defined interval or whether the approaches discussed improved a measured endpoint.

The meeting operated like a professional priority-setting forum rather than a clinical trial. Its stated commitments concern dignity, quality of life, early diagnosis and treatment. However, no patient-level endpoint, comparative group or follow-up period was reported, so the assertion of progress cannot be assigned an effect size.

The opening brought together several IADVL officeholders. Dr Jagadish P served as president; Dr Swetha Prabhu was scientific chairperson; Dr Chennabasappa Mendagudli was treasurer; and Dr Soumyashree Krishna was joint secretary. Other dignitaries also attended.

Padmalatha Niranjan, executive director of SDM University, inaugurated the exhibition associated with the meeting. The account does not describe the exhibits, exhibitors, demonstrations or products. It consequently offers no basis to assess what visitors encountered or whether the exhibition meaningfully connected with the conference themes.

The reported messages ask clinicians to widen dermatology’s endpoint beyond treatment of the skin condition alone. That approach would place patient dignity and quality of life at the center of care, while early diagnosis and appropriate treatment remain the clinical means. The report does not specify how those aims should be operationalized or audited.

The conference’s forward-looking agenda rests on three declared areas: innovation in dermatology, evolving aesthetics and emerging AI. Its next stage will require the same specificity applied to dignity and early treatment: named interventions, transparent evidence, defined patient groups and measurable benefits. Until those details emerge, the event documents professional intent more clearly than demonstrated clinical progress.